Mubadala Capital, established as the financial investment arm of Mubadala Development Company, in various transactions, including its 2022 acquisition of Canada Cartage Corporation and its recently completed acquisition, together with members of Fortress management, of all of the indirect interests in Fortress Investment Group LLC.

Mubadala Investment Company, a public joint stock company wholly owned by the Government of the Emirate of Abu Dhabi, in various transactions, including its global business partnership with General Electric Company, its investment in the EBX Group (and related restructuring transactions), its investment with Trafigura Pte. Ltd. In MMX Porte Sudeste and in connection with the establishment of several private lending programs with global financial institution origination partners, which provide financing solutions to U.S. and European middle-market businesses.

Ardagh Group in various transactions, including its US$8.3 billion “de-SPAC” transaction involving the combination of its metal packaging business with Gores Holdings V, Inc., a special purpose acquisition company, the combination of its Food & Specialty Metal Packaging business with the packaging business of Element Holdings II L.P., an entity controlled by The Ontario Teachers' Pension Plan, to form Trivium Packaging, its acquisition of certain metal beverage can manufacturing assets from Ball Corporation and Rexam PLC with an enterprise value of $3.42 billion, and its sale of Anchor Glass Container Corporation to an affiliate of KPS Capital Partners LP.

Boston Scientific Corporation in various transactions, including its pending acquisition of Axonics Inc., a publicly traded MedTech company, for approximately $3.7 billion, its 2022 acquisition of Apollo Endosurgery, Inc., a Delaware public company, its acquisition of Baylis Medical Company, a privately held Canadian company, its acquisition of BTG plc, a public company organized under the laws of England and Wales, its acquisition of the men's health and prostate health businesses of Endo International plc, the sale of its neurovascular business to Stryker Corporation, its acquisition of and the restructuring of its interests in Advanced Bionics Corporation, its acquisition of Guidant Corporation, the sale of Guidant's vascular businesses to Abbott Laboratories and in various corporate and other transactional matters.

Atrion Corporation in its pending acquisition by Nordson Corporation for an aggregate equity value of approximately $815 million.

Raytheon Company in various transactions, including its 2020 “merger of equals” combination with United Technologies Corporation.